- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Sheba Medical Center to evaluate Valion Bio's Entolimod in trial | 4 | Investing.com | ||
| Mo | Sheba Medical Center prüft Entolimod von Valion Bio in klinischer Studie | 1 | Investing.com Deutsch | ||
| 17.07. | Valion Bio, Inc. - S-1, General form for registration of securities | 1 | SEC Filings | ||
| VALION BIO Aktie jetzt für 0€ handeln | |||||
| 14.07. | Valion Bio, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.06. | Valion Bio, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 05.06. | Valion Bio, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 03.06. | Valion Bio, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Valion Bio outlines end-2026 Entolimod GMP validation target as NIAID funds GI-ARS BLA-enabling work | 2 | Seeking Alpha | ||
| 14.05. | Valion Bio, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.05. | Valion Bio subsidiary secures exclusive NMR platform license | 1 | Investing.com | ||
| 14.05. | Valion Bio, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.05. | Valion Bio, Inc.: Valion Bio Reports First Quarter 2026 Financial Results | 229 | PR Newswire | First Reporting Quarter as Valion Bio Marked by Continued Advancement of the Entolimod Platform, Broader Government Engagement, and Continued Integration of Velocity... ► Artikel lesen | |
| 05.05. | Valion Bio receives protocol for radiation syndrome drug study | 3 | Investing.com | ||
| 05.05. | Tivic Health Systems, Inc.: Valion Bio Receives First FDA-precedent Study Protocol From Niaid For Entolimod; Federal Agency To Fully Fund Bla-enabling In Vivo Program And Co-navigate FDA Submission | 227 | PR Newswire | Initial Study to Evaluate Entolimod for Gastrointestinal Tissue Preservation in Partial-Body Acute Radiation Syndrome - an Indication for Which No Currently Approved... ► Artikel lesen | |
| 04.05. | Valion Bio, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.04. | Tivic Health Systems Rebrands to Valion Bio | 2 | Contract Pharma | ||
| 24.04. | Tivic Health Systems (TIVC) Stock Surges Over 24% After Hours: Here's What Is Happening | 2 | Benzinga.com | ||
| 23.04. | Tivic Health Systems, Inc.: Tivic Health Systems Rebrands as Valion Bio, Reflecting Completed Transformation into a Late-Stage Biopharmaceutical Company with Government-Backed Asset and Potential Multiple Revenue Stream Model | 264 | PR Newswire | Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod Toward BARDA Funding and Strategic National Stockpile Procurement... ► Artikel lesen | |
| 23.04. | Tivic Health Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.04. | Tivic Health Systems, Inc. - S-1, General form for registration of securities | - | SEC Filings |
1 2 3 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,070 | -4,36 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn Wound Irrigation Solution | BOULDER, CO / ACCESS Newswire / June 30, 2026 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced it has received a new 510(k)... ► Artikel lesen | |
| TANDEM DIABETES | 14,300 | -5,30 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| VERU | 2,250 | 0,00 % | Top Biotech Gainers: VERU Teams Up With NVO, ABSI On Watch, ALVO Resubmits BLAs To FDA... | REYKJAVIK (dpa-AFX) - Thursday's top gainers include Veru, following a Novo Nordisk collaboration; Health Catalyst, following a divestment of its revenue workflow and analytics software business... ► Artikel lesen | |
| SENSEONICS | 4,080 | +0,99 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results | Generated Q4 revenue of $14.3 million, an increase of 72% year-over-year Received CE Mark approval for commercialization of Eversense 365 in Europe Launched first Eversense 365 AID system integration... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,950 | +2,60 % | Tempest Therapeutics: Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T | Tempest's TPST-4003 is a next-generation in vivo CAR-T candidate combining proprietary CD7-targeted mRNA/LNP delivery with a dual-target CD19/BCMA CAR construct designed to enable broad B-cell lineage... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 17,000 | 0,00 % | Aktien New York Ausblick: Nasdaq erholt - Comcast-Aufspaltung beflügelt Branche | NEW YORK (dpa-AFX) - Die Anleger dürften den jüngsten Kursrückschlag an der New Yorker Tech-Börse Nasdaq direkt zum Wiedereinstieg nutzen. Im Fokus stehen am Montag die jüngste Entspannung im davor... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 1,450 | +2,84 % | SINTX Technologies, Inc.: SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program | SALT LAKE CITY, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), a leader in advanced biomaterials and silicon nitride technologies for medical... ► Artikel lesen | |
| VYOME | 2,070 | +0,49 % | Mitschrift des Earnings Call: Vyome Holdings weist für Q1 2026 eine starke Cash-Position aus | ||
| VIVANI MEDICAL | 1,110 | 0,00 % | Vivani Medical, Inc.: Vivani Medical schließt Vereinbarung mit Novo Nordisk zur Evaluierung von NPM-139, einem miniaturisierten, ultra-langwirkenden Semaglutid-Implantat zur langfristigen Gewichtsregulierung | Novo Nordisk wird eine nicht-exklusive interne Evaluierung der von Vivani hergestellten Semaglutid-Implantate durchführenALAMEDA, Kalifornien, July 08, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc.... ► Artikel lesen | |
| STEREOTAXIS | 1,222 | +7,19 % | Stereotaxis, Inc.: University of Szeged Pioneers First Robotic Cardiology Program in Hungary | First Robotic Magnetic Navigation system installed in HungaryUniversity of Szeged, led by Cardiology Chief Dr. Szili-Torok, expected to treat hundreds of patients annually with all forms of cardiac... ► Artikel lesen | |
| VIEMED HEALTHCARE | 9,950 | -1,49 % | Viemed Healthcare, Inc.: Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details | LAFAYETTE, LA / ACCESS Newswire / July 21, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic... ► Artikel lesen | |
| VIVOS THERAPEUTICS | 0,400 | +1,73 % | Vivos Therapeutics, Inc: Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity | LITTLETON, Colo., June 22, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment... ► Artikel lesen | |
| TENON MEDICAL | 0,190 | -0,05 % | Tenon Medical, Inc. Announces Regained Compliance with Nasdaq Stockholders' Equity Requirement | LOS GATOS, CA / ACCESS Newswire / July 20, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic... ► Artikel lesen | |
| SEASTAR MEDICAL | 3,770 | +0,53 % | SeaStar Medical Holding Corp - S-8, Securities to be offered to employees in employee benefit plans |
VALION BIO INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,004 (-1,31 %) liegt der Kurs bei 0,293 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VALION BIO INC finden Sie auf Wallstreet Online.